PRIMUM NON NOCERE: now and again an echo of DPD with capecitabine.
作者信息
Ciccolini Joseph, Lacarelle Bruno, Milano Gérard
机构信息
SMARTc Unit, Inserm S-911 La Timone University Hospital of Marseille and Aix Marseille Universite, Marseille, France.
Oncopharmacology Unit, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06102, Nice cedex, France.
出版信息
Cancer Chemother Pharmacol. 2017 Dec;80(6):1265-1266. doi: 10.1007/s00280-017-3437-z. Epub 2017 Oct 13.
PMID:29030673
Abstract
摘要
相似文献
1
PRIMUM NON NOCERE: now and again an echo of DPD with capecitabine.首要的是不伤害：偶尔会出现卡培他滨导致的双相障碍回声。 （注：这里的翻译可能需要结合更专业的医学背景知识来准确理解，仅从字面看这样翻译，可能“双相障碍回声”不是非常精准的医学术语表达，具体含义需结合原文出处进一步明确）
Cancer Chemother Pharmacol. 2017 Dec;80(6):1265-1266. doi: 10.1007/s00280-017-3437-z. Epub 2017 Oct 13.
2
Capecitabine Toxicity and Dihydropyrimidine Dehydrogenase Deficiency.卡培他滨毒性与二氢嘧啶脱氢酶缺乏症
Am J Ther. 2018 Nov/Dec;25(6):e742-e743. doi: 10.1097/MJT.0000000000000753.
3
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.治疗前血清尿嘧啶浓度作为严重和致命性氟嘧啶相关毒性的预测指标。
Br J Cancer. 2017 May 23;116(11):1415-1424. doi: 10.1038/bjc.2017.94. Epub 2017 Apr 20.
4
[Dihydropyrimidine dehydrogenase deficiency causes severe adverse effects of capecitabine].二氢嘧啶脱氢酶缺乏导致卡培他滨的严重不良反应
Nihon Shokakibyo Gakkai Zasshi. 2018;115(3):290-298. doi: 10.11405/nisshoshi.115.290.
5
Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.卡培他滨因二氢嘧啶脱氢酶（DPD）缺乏导致严重毒性及低剂量5-氟尿嘧啶成功治疗
J Gastrointest Cancer. 2017 Mar;48(1):66-69. doi: 10.1007/s12029-015-9797-x.
6
Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.卡培他滨所致严重胃肠道疾病伴二氢嘧啶脱氢酶缺乏症：1例报告及文献复习
Intern Med. 2022 Aug 15;61(16):2449-2455. doi: 10.2169/internalmedicine.8636-21. Epub 2022 Feb 1.
7
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.卡培他滨在一名存在 DPD 缺乏的患者中出现严重毒性：为什么我们应该在所有患者使用高剂量氟嘧啶之前检测 DPD 缺乏。
Cancer Chemother Pharmacol. 2021 Apr;87(4):579-583. doi: 10.1007/s00280-021-04233-1. Epub 2021 Feb 15.
8
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?氟嘧啶诱导的毒性与二氢嘧啶脱氢酶缺乏症：一例早期发生的致命性卡培他滨诱导毒性病例报告及文献综述。三醋酸尿苷：作为解毒剂的疗效与安全性。在美国以外地区是否可获取？
J Oncol Pharm Pract. 2020 Apr;26(3):747-753. doi: 10.1177/1078155219865597. Epub 2019 Aug 5.
9
Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency.基于卡培他滨对一名具有新型二氢嘧啶脱氢酶（DPYD）基因型和完全二氢嘧啶脱氢酶缺乏症患者的治疗。
Int J Cancer. 2018 Jan 15;142(2):424-430. doi: 10.1002/ijc.31065. Epub 2017 Sep 30.
10
Toxicity Associated with Capecitabine in Patients Suffering from Dihydropyrimidine Dehydrogenase Deficiency.二氢嘧啶脱氢酶缺乏症患者中与卡培他滨相关的毒性
Chemotherapy. 2014;60(5-6):353-5. doi: 10.1159/000438665. Epub 2015 Sep 2.
引用本文的文献
1
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.5-氟尿嘧啶治疗药物监测与二氢嘧啶脱氢酶（DPD）表型评估相结合可能会减少5-氟尿嘧啶暴露不足的情况。
Pharmaceuticals (Basel). 2020 Nov 23;13(11):416. doi: 10.3390/ph13110416.
Zotero 插件